UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 37

Sortiert nach

O‐glycosylated versus non‐glycosylated MUC1‐derived peptides as potential targets for cytotoxic immunotherapy of carcinoma

Clinical and experimental immunology, 2006-01, Vol.143 (1), p.139-149

2006

Volltextzugriff (PDF)

'1-8 interferon inducible gene family' : putative colon carcinoma-associated antigens

British journal of cancer, 2007-12, Vol.97 (12), p.1655-1663

2007

Volltextzugriff (PDF)

MAGE-A8 overexpression in transitional cell carcinoma of the bladder: identification of two tumour-associated antigen peptides

British journal of cancer, 2004-07, Vol.91 (2), p.398-407

2004

Volltextzugriff (PDF)

Combined Dendritic Cell Cryotherapy of Tumor Induces Systemic Antimetastatic Immunity

Clinical cancer research, 2005-07, Vol.11 (13), p.4955-4961

2005

Volltextzugriff (PDF)

DAP kinase links the control of apoptosis to metastasis

Nature (London), 1997-11, Vol.390 (6656), p.180-184

1997

Volltextzugriff (PDF)

Identification of shared tumor-associated antigen peptides between two spontaneous lung carcinomas

The Journal of immunology (1950), 1997-12, Vol.159 (12), p.6030

1997

Volltextzugriff (PDF)

Human CTL epitopes prostatic acid phosphatase-3 and six-transmembrane epithelial antigen of prostate-3 as candidates for prostate cancer immunotherapy

Cancer research (Chicago, Ill.), 2005-07, Vol.65 (14), p.6435-6442

2005

Volltextzugriff (PDF)

Expression of two H-2K genes, syngeneic and allogeneic, as a strategy for potentiating immune recognition of tumor cells

Gene therapy, 1995-12, Vol.2 (10), p.757

1995

Volltextzugriff (PDF)

Antigenicity and immunogenicity of an intracellular delivery system of major histocompatibility complex class I epitopes that bypasses proteasome processing

Journal of immunotherapy, 2000-11, Vol.23 (6), p.622-630

2000

Volltextzugriff (PDF)

Interleukin 6 gene transfection into Lewis lung carcinoma tumor cells suppresses the malignant phenotype and confers immunotherapeutic competence against parental metastatic cells

Cancer research (Chicago, Ill.), 1992-07, Vol.52 (13), p.3679-3686

1992

Volltextzugriff (PDF)

Regression of established murine carcinoma metastases following vaccination with tumour-associated antigen peptides

Nature medicine, 1995-11, Vol.1 (11), p.1179-1183

1995

Volltextzugriff (PDF)

ORIGINAL ARTICLE: O-glycosylated versus non-glycosylated MUC1-derived peptides as potential targets for cytotoxic immunotherapy of carcinoma

Clinical and experimental immunology, 2006-01, Vol.143 (1), p.139-149

2006

Volltextzugriff (PDF)

MHC class I‐restricted epitope spreading in the context of tumor rejection following vaccination with a single immunodominant CTL epitope

European journal of immunology, 1999-10, Vol.29 (10), p.3295-3301

1999

Volltextzugriff (PDF)

In vivo rejection of tumor cells dependent on CD8 cells that kill independently of perforin and FasL

Cancer gene therapy, 2004-03, Vol.11 (3), p.237-248

2004

Volltextzugriff (PDF)

'1-8 interferon inducible gene family': putative colon carcinoma-associated antigens

British journal of cancer, 2007-12, Vol.97 (12), p.1655-1663

2007

Volltextzugriff (PDF)

Combined vaccination with major histocompatibility class I and interleukin 2 gene-transduced melanoma cells synergizes the cure of postsurgical established lung metastases

Cancer research (Chicago, Ill.), 1995-11, Vol.55 (21), p.4941-4949

1995

Volltextzugriff (PDF)

Expression of FasL by tumor cells does not abrogate anti-tumor CTL function

Immunology letters, 2004-02, Vol.91 (2-3), p.119-126

2004

Volltextzugriff (PDF)

In vivo rejection of tumor cells dependent on CD8 cells that kill independently of perforin and FasL

Cancer gene therapy, 2004-04, Vol.11 (4), p.307

2004

Volltextzugriff (PDF)

Induction of antitumor immunity with modified autologous cells expressing membrane-bound murine cytokines

Journal of interferon & cytokine research, 1999-12, Vol.19 (12), p.1391-1401

1999

Volltextzugriff (PDF)

Effective anti‐metastatic melanoma vaccination with tumor cells transfected with MHC genes and/or infected with newcastle disease virus (NDV)

International journal of cancer, 1994-12, Vol.59 (6), p.796-801

1994

Volltextzugriff (PDF)

Induction of antitumor immunity by proteasome-inhibited syngeneic fibroblasts pulsed with a modified TAA peptide

International journal of cancer, 2000-01, Vol.85 (2), p.236-242

2000

Volltextzugriff (PDF)

Antimetastatic vaccination against Lewis lung carcinoma with autologous tumor cells modified to express murine interleukin 12

Clinical & experimental metastasis, 1998-10, Vol.16 (7), p.623-632

1998

Volltextzugriff (PDF)

Modification of PDGFα receptor expression or function alters the metastatic phenotype of 3LL cells

Oncogene, 1997-09, Vol.15 (13), p.1545-1554

1997

Volltextzugriff (PDF)

MHC class I-restricted epitope spreading in the context of tumor rejection following vaccination with a single immunodominant CTL epitope

European journal of immunology, 1999-10, Vol.29 (10), p.3295-3301

1999

Volltextzugriff (PDF)

Immunotherapy via gene therapy: comparison of the effects of tumor cells transduced with the interleukin-2, interleukin-6, or interferon-gamma genes

Journal of immunotherapy with emphasis on tumor immunology, 1993-10, Vol.14 (3), p.191

1993

Volltextzugriff (PDF)

1 – 25 von 37

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(37)
Mit Volltextzugriff
(34)

Publikationsform

Artikel
(37)

Sprache

Englisch
(37)
Japanisch
(4)

Erscheinungsjahr

n.n

Thema

Science & Technology
(27)
Animals
(26)
Mice
(26)
Life Sciences & Biomedicine
(25)
T-Lymphocytes, Cytotoxic - Immunology
(17)
Mice, Inbred C57bl
(16)
Oncology
(16)
Biological And Medical Sciences
(15)
Medical Sciences
(12)
Immunology
(10)
Immunotherapy
(10)
Transfection
(9)
Pharmacology. Drug Treatments
(8)
Tumor Cells, Cultured
(8)
Tumors
(8)
Antineoplastic Agents
(7)
Female
(7)
Lung Neoplasms - Therapy
(7)
Medicine, Research & Experimental
(7)
Research & Experimental Medicine
(7)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

O‐glycosylated versus non‐glycosylated MUC1‐derived peptides as potential targets for cytotoxic immunotherapy of carcinoma

'1-8 interferon inducible gene family' : putative colon carcinoma-associated antigens

MAGE-A8 overexpression in transitional cell carcinoma of the bladder: identification of two tumour-associated antigen peptides

Combined Dendritic Cell Cryotherapy of Tumor Induces Systemic Antimetastatic Immunity

DAP kinase links the control of apoptosis to metastasis

Identification of shared tumor-associated antigen peptides between two spontaneous lung carcinomas

Human CTL epitopes prostatic acid phosphatase-3 and six-transmembrane epithelial antigen of prostate-3 as candidates for prostate cancer immunotherapy

Expression of two H-2K genes, syngeneic and allogeneic, as a strategy for potentiating immune recognition of tumor cells

Antigenicity and immunogenicity of an intracellular delivery system of major histocompatibility complex class I epitopes that bypasses proteasome processing

Interleukin 6 gene transfection into Lewis lung carcinoma tumor cells suppresses the malignant phenotype and confers immunotherapeutic competence against parental metastatic cells

Regression of established murine carcinoma metastases following vaccination with tumour-associated antigen peptides

ORIGINAL ARTICLE: O-glycosylated versus non-glycosylated MUC1-derived peptides as potential targets for cytotoxic immunotherapy of carcinoma

MHC class I‐restricted epitope spreading in the context of tumor rejection following vaccination with a single immunodominant CTL epitope

In vivo rejection of tumor cells dependent on CD8 cells that kill independently of perforin and FasL

'1-8 interferon inducible gene family': putative colon carcinoma-associated antigens

Combined vaccination with major histocompatibility class I and interleukin 2 gene-transduced melanoma cells synergizes the cure of postsurgical established lung metastases

Expression of FasL by tumor cells does not abrogate anti-tumor CTL function

In vivo rejection of tumor cells dependent on CD8 cells that kill independently of perforin and FasL

Induction of antitumor immunity with modified autologous cells expressing membrane-bound murine cytokines

Effective anti‐metastatic melanoma vaccination with tumor cells transfected with MHC genes and/or infected with newcastle disease virus (NDV)

Induction of antitumor immunity by proteasome-inhibited syngeneic fibroblasts pulsed with a modified TAA peptide

Antimetastatic vaccination against Lewis lung carcinoma with autologous tumor cells modified to express murine interleukin 12

Modification of PDGFα receptor expression or function alters the metastatic phenotype of 3LL cells

MHC class I-restricted epitope spreading in the context of tumor rejection following vaccination with a single immunodominant CTL epitope

Immunotherapy via gene therapy: comparison of the effects of tumor cells transduced with the interleukin-2, interleukin-6, or interferon-gamma genes

Suchergebnisse filtern